![Cindy Parseghian](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Cindy Parseghian
Fondatore presso The Ara Parseghian Medical Research Foundation
Profilo
Cindy Parseghian is the founder of The Ara Parseghian Medical Research Foundation.
She is currently the Chairman at the National Institute of Neurological Disorders & Stroke and the Director at the Translational Genomics Research Institute.
Previously, she served as the Chairman-Advisory Board at the Critical Path Institute and as a Director at the United Way of Tucson & Southern Arizona, Inc. She completed her undergraduate degree at Princeton University.
Posizioni attive di Cindy Parseghian
Società | Posizione | Inizio |
---|---|---|
The Ara Parseghian Medical Research Foundation | Fondatore | - |
National Institute of Neurological Disorders & Stroke | Presidente | - |
Translational Genomics Research Institute
![]() Translational Genomics Research Institute Miscellaneous Commercial ServicesCommercial Services Translational Genomics Research Institute operates as non-profit organization. It focuses on developing earlier diagnoses and smarter treatments. Translational research applies to the development of diagnostics, prognostics, and therapies for cancer, neurological disorders, diabetes, and other complex diseases. The company was founded by Jeffrey M. Trent in 2002 and is headquartered in Phoenix, AZ. | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Cindy Parseghian
Società | Posizione | Fine |
---|---|---|
Critical Path Institute
![]() Critical Path Institute Miscellaneous Commercial ServicesCommercial Services Critical Path Institute is a nonprofit organization established in 2005 as a public and private partnership with the FDA's Critical Path Initiative program. The non-profit company is based in Tucson, AZ, and operates from Ireland with additional staff in multiple other locations. The company's mission is to catalyze the development of new approaches that advance medical innovation and regulatory science, accelerating the path to a healthier world. The company orchestrates the development of drug development tools through an innovative, collaborative approach to the sharing of data and expertise, and accelerate the pace and reduce the costs of medical product development by building consensus among the participating institutions. The company was founded in 2005 by Raymond L. Woosley, Glenn C. Rice. Daniel M. Jorgensen has been the CEO of the company since 2022. | Corporate Officer/Principal | - |
United Way of Tucson & Southern Arizona, Inc.
![]() United Way of Tucson & Southern Arizona, Inc. Miscellaneous Commercial ServicesCommercial Services United Way of Tucson & Southern Arizona, Inc. provides health and human services. The firm’s programs include cradle to career, days of caring and volunteer income tax assistance. The Company is headquartered in Tucson, AZ. | Direttore/Membro del Consiglio | - |
Formazione di Cindy Parseghian
Princeton University | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 5 |
---|---|
United Way of Tucson & Southern Arizona, Inc.
![]() United Way of Tucson & Southern Arizona, Inc. Miscellaneous Commercial ServicesCommercial Services United Way of Tucson & Southern Arizona, Inc. provides health and human services. The firm’s programs include cradle to career, days of caring and volunteer income tax assistance. The Company is headquartered in Tucson, AZ. | Commercial Services |
The Ara Parseghian Medical Research Foundation | |
Critical Path Institute
![]() Critical Path Institute Miscellaneous Commercial ServicesCommercial Services Critical Path Institute is a nonprofit organization established in 2005 as a public and private partnership with the FDA's Critical Path Initiative program. The non-profit company is based in Tucson, AZ, and operates from Ireland with additional staff in multiple other locations. The company's mission is to catalyze the development of new approaches that advance medical innovation and regulatory science, accelerating the path to a healthier world. The company orchestrates the development of drug development tools through an innovative, collaborative approach to the sharing of data and expertise, and accelerate the pace and reduce the costs of medical product development by building consensus among the participating institutions. The company was founded in 2005 by Raymond L. Woosley, Glenn C. Rice. Daniel M. Jorgensen has been the CEO of the company since 2022. | Commercial Services |
National Institute of Neurological Disorders & Stroke | Government |
Translational Genomics Research Institute
![]() Translational Genomics Research Institute Miscellaneous Commercial ServicesCommercial Services Translational Genomics Research Institute operates as non-profit organization. It focuses on developing earlier diagnoses and smarter treatments. Translational research applies to the development of diagnostics, prognostics, and therapies for cancer, neurological disorders, diabetes, and other complex diseases. The company was founded by Jeffrey M. Trent in 2002 and is headquartered in Phoenix, AZ. | Commercial Services |
- Borsa valori
- Insiders
- Cindy Parseghian